Bluestone/Leukemia Drug Update

As fellow reluctant diabetics know, Dr. Jeffrey Bluestone believes the results of his highly publicized type-1-diabetes/leukemia drug study have been exaggerated. (See here.) But this latest article from First Coast News suggests that even though the excitement surrounding the trial was overblown, there still might be human trials starting within a year. Very interesting. Granted, it’s true that leukemia patients are probably likely to put up with more complications than diabetics, considering the immediately life-threatening nature of their disease — but it’ll still be interesting to see where these trials lead.

Catherine Price

Catherine Price (www.catherine-price.com) was diagnosed with Type 1 diabetes when she was 22 years old. She has written for publications including The Best American Science Catherine Price is a professional journalist who was diagnosed with Type 1 diabetes when she was 22 years old. Her work has been featured in publications including The Best American Science Writing, The New York Times, Popular Science, The Los Angeles Times, The San Francisco Chronicle, The Washington Post Magazine, Salon, Slate, Men’s Journal, Health Magazine, The Oprah Magazine, and Outside, among others. A graduate of Yale and UC Berkeley’s Graduate School of Journalism

View Author Blog

Catherine Price

Catherine Price was diagnosed with Type 1 diabetes when she was 22 years old. She has written for publications including The Best American Science Catherine Price is a professional journalist who was diagnosed with Type 1 diabetes when she was 22 years old. Her work has been featured in publications including The Best American Science Writing, The New York Times, Popular Science, The Los Angeles Times, The San Francisco Chronicle, The Washington Post Magazine, Salon, Slate, Men’s Journal, Health Magazine, The Oprah Magazine, and Outside, among others. A graduate of Yale and UC Berkeley’s Graduate School of Journalism